EMERGING GLOBAL MARKETS FOR NOVEL PERIPHERAL INTERVENTIONAL AND NEUROINTERVENTIONAL THERAPEUTIC SYSTEMS

189 Pages | 49 Exhibits | 2015 Analysis | Forecasts Through 2018

OVERVIEW:
Peripheral vascular disease and acute stroke are major public health problems worldwide, and the incidence and prevalence of these conditions is rising, reflecting both the aging of the population in many regions of the world, and continuing growth in the incidence of problematic risk factors such as diabetes, hypertension and obesity. In recent years, device manufacturers have developed a number of novel and highly promising percutaneous revascularization technologies including peripheral drug-eluting balloon angioplasty systems, peripheral drug-eluting stents, and cerebral thrombectomy devices for acute ischemic stroke management. These new devices are designed to remedy major functional drawbacks of existing endovascular therapies and offer new efficacious treatment options for the management of symptomatic limb- and life-threatening peripheral arterial disorders (particularly cases involving critical limb ischemia) and severe cerebral artery occlusions manifested by acute ischemic stroke.

This comprehensive report presents a worldwide market analysis of the procedure volumes, sales and share by supplier for these three promising device market segments, for three major regions including the United States, the largest Western European countries (France, Germany, Italy, Spain, and the United Kingdom), and the major Asia-Pacific countries of China, India and Japan, from 2013 forecast through 2018. Combined global sales of these devices totaled approximately $320 million worldwide in 2013, and at an anticipated 35.9% compound annual growth rate, are expected to exceed $1.4 billion in 2018.

TABLE OF CONTENTS:
1. EXECUTIVE SUMMARY
 
1.1 Drug-Eluting Balloon Product Market 
1.2 Peripheral Drug-Eluting Stent Market 
1.3 Cerebral Thrombectomy Product Market 

Exhibit 1-1: Projected Dynamics of Novel Peripheral Vascular and Neurointerventional Procedures, by Region, 2013-2018E 
Exhibit 1-2: Projected Dynamics of the Worldwide Market for Novel Peripheral Vascular and Neurovascular Therapeutic Systems, 2013-2018E 
Exhibit 1-3: Estimated Geographic Distribution of Novel Peripheral Interventional and Neurointerventional System Sales, 2013 vs. 2018E 
Exhibit 1-4: Estimated Relative Market Dollar Volumes of Novel Peripheral Interventional and Neurointerventional Systems, 2013 vs. 2018E 
Exhibit 1-5: Projected Dynamics of Peripheral DEB Product Market, 2013-2018E 
Exhibit 1-6: Projected Geographic Distribution of DEB Sales, 2013 vs. 2018E 
Exhibit 1-7: Projected Dynamics of Peripheral DES Product Market, 2013-2018E 
Exhibit 1-8: Estimated Geographic Distribution of Peripheral DES System Sales, 2013 vs. 2018E 
Exhibit 1-9: Projected Dynamics of Cerebral Thrombectomy Products Market, 2013-2018E 
Exhibit 1-10: Estimated Geographic Distribution of Cerebral Thrombectomy System Sales, 2013 vs. 2018E 

2. GLOBAL HEALTHCARE MARKET ENVIRONMENT

2.1 United States 
	2.1.1 U.S. Interventional Radiology and Neuroradiology Device Marketplace 
2.2 Major Western European States 
	2.2.1 Overview of European Healthcare 
		2.2.1.1 Healthcare Spending and Reforms 
		2.2.1.2 Healthcare Facilities and Manpower 
		2.2.1.3 Reimbursement 
		2.2.1.4 Impact of the European Union 
	2.2.2 National Healthcare Profiles 
		2.2.2.1 France 
		2.2.2.2 Germany 
		2.2.2.3 Italy 
		2.2.2.4 Spain 
		2.2.2.5 United Kingdom 
2.3 Major Asian States 
	2.3.1 China 
	2.3.2 India 
	2.3.3 Japan 

Exhibit 2-1: United States, Selected Healthcare/Public Health Indicators, 2013 
Exhibit 2-2: France, Selected Healthcare/Public Health Indicators, 2013 
Exhibit 2-3: Germany, Selected Healthcare/Public Health Indicators, 2013 
Exhibit 2-4: Italy, Selected Healthcare/Public Health Indicators, 2013 
Exhibit 2-5: Spain, Selected Healthcare/Public Health Indicators, 2013 
Exhibit 2-6: United Kingdom, Selected Healthcare/Public Health Indicators, 2013 
Exhibit 2-7: China, Selected Healthcare/Public Health Indicators, 2013 
Exhibit 2-8: India, Selected Healthcare/Public Health Indicators, 2013 
Exhibit 2-9: Japan, Selected Healthcare/Public Health Indicators, 2013 

3. ETIOLOGY AND EPIDEMIOLOGY OF ACUTE AND CHRONIC MEDICAL CONDITIONS TARGETED BY NOVEL INTERVENTIONAL TECHNOLOGIES

3.1 Symptomatic Peripheral Vascular Disease and Critical Limb Ischemia 
	3.1.1 Peripheral Atherosclerosis 
	3.1.2 Critical Limb Ischemia 
	3.1.3 Established Treatment Modalities for Symptomatic PAD and CLI 
3.2 Acute Stroke 
	3.2.1 Etiology of Stroke 
	3.2.2 Acute Ischemic Stroke 
		3.2.2.1 Thrombotic Stroke - Causes and Mechanisms 
		3.2.2.2 Embolic Stroke - Causes and Mechanisms 
		3.2.2.3 Hypoperfusion Stroke - Causes and Mechanisms 
		3.2.2.4 Symptoms and Risk Factors for Ischemic Stroke 
		3.2.2.5 Management of Acute Ischemic Stroke Patients 
			3.2.2.5.1 Ischemic Stroke Diagnostics 
			3.2.2.5.2 Therapeutic Management of Acute Cerebral Ischemia 
		3.2.2.6 Transient Ischemic Attack 

Exhibit 3-1: Peripheral Artery Disease and Critical Limb Ischemia, Selected Clinical Characteristics 
Exhibit 3-2: Estimated and Projected Incidence of Critical Limb Ischemia and Limb Amputation in Covered Market Geographies, 2013-2018E 
Exhibit 3-3: Clinical Features and Characteristics of Ischemic Stroke 
Exhibit 3-4: Incidence of Acute Ischemic Stroke and Associated Mortality Data for Covered Market Geographies, 2013-2018E 

4. NOVEL PERIPHERAL AND NEUROINTERVENTIONAL TECHNOLOGIES FOR CLI AND ACUTE ISCHEMIC STROKE

4.1 Peripheral Drug-Eluting Balloon Technologies 
	4.1.1 Carrier Excipients for Coating 
	4.1.2 Second-Generation DEB Technologies Under Development 
	4.1.3 Accumulated Clinical Experience with Drug-Eluting Balloons 
	4.1.4 Drug-Eluting Balloon Angioplasty Procedure Volumes 
4.2 Peripheral Drug-Eluting Stent Technologies 
	4.2.1 Anti-Restenotic Drugs 
	4.2.2 Accumulated Clinical Experience with Peripheral DES 
	4.2.3 Peripheral Drug-Eluting Stent Procedure Volumes 
4.3 Cerebral Thrombectomy Systems for Acute Ischemic Stroke Management 
	4.3.1 Accumulated Clinical Experience with Cerebral Thrombectomy Systems 
	4.3.2 Cerebral Thrombectomy Procedure Volumes 

Exhibit 4-1: DEB Performance Data from Major Trials in Symptomatic Patients with SFA Occlusions 
Exhibit 4-2: DEB Performance Data from Major Trials in Symptomatic CLI Patients with Below-the-Knee Arterial Occlusions 
Exhibit 4-3: Estimated and Projected Volumes of DEB Angioplasty Procedures, 2013-2018E 
Exhibit 4-4: DES Performance Data from Major Trials in Symptomatic CLI Patients with SFA and BTK Occlusions 
Exhibit 4-5: Projected Dynamics of Peripheral Drug-Eluting Stenting Procedures, 2013-2018E 
Exhibit 4-6: Findings from Major Clinical Trials with Cerebral Thrombectomy Systems 
Exhibit 4-7: Projected Dynamics of Cerebral Thrombectomy Procedures in Covered Market Geographies, 2013-2018E 

5. WORLDWIDE MARKET FOR NOVEL PERIPHERAL AND NEUROINTERVENTIONAL THERAPEUTIC SYSTEMS

5.1 Peripheral Drug-Eluting Balloon Angioplasty Systems 
	5.1.1 Peripheral Drug-Eluting Balloon Angioplasty Systems on the Market and Under Development 
	5.1.2 Market Forecast 
	5.1.3 Competitive Analysis 
5.2 Peripheral Drug-Eluting Stent Technologies 
	5.2.1 Peripheral Drug-Eluting Stents on the Market and Under Development 
	5.2.2 Peripheral Drug-Eluting Stent Product Market 
	5.2.3 Competitive Analysis 
5.3 Cerebral Thrombectomy Systems for Acute Ischemic Stroke Management 
	5.3.1 Cerebral Thrombectomy Systems on the Market 
	5.3.2 Cerebral Thrombectomy Product Market 
	5.3.3 Competitive Analysis 

Exhibit 5-1: Projected Dynamics of Novel Peripheral Vascular and Neurointerventional Procedures, 2013-2018E 
Exhibit 5-2: Projected Dynamics of the Worldwide Market for Novel Peripheral Vascular and Neurovascular Therapeutic Systems, 2013-2018E 
Exhibit 5-3: Estimated Geographic Distribution of Novel Peripheral Interventional and Neurointerventional System Sales, 2013 vs. 2018E 
Exhibit 5-4: Estimated Relative Market Dollar Volumes of Novel Peripheral Interventional and Neurointerventional Systems, 2013 vs. 2018E 
Exhibit 5-5: Selected Peripheral Drug-Eluting Balloon Angioplasty Systems on the Market 
Exhibit 5-6: Projected Dynamics of the Peripheral DEB Product Market,2013-2018E 
Exhibit 5-7: Estimated 2013 Global Market Shares of the Leading Suppliers of Peripheral DEB Systems 
Exhibit 5-8: Estimated Geographic Distribution of Peripheral DEB System Sales, Tabular, 2013 vs. 2018E 
Exhibit 5-9: Estimated Geographic Distribution of Peripheral DEB System Sales, Graphic, 2013 vs. 2018E 
Exhibit 5-10: Selected Peripheral Drug-Eluting Stenting Systems on the Market and Under Development 
Exhibit 5-11: Projected Dynamics of Peripheral DES Product Market, 2013-2018E 
Exhibit 5-12: Estimated 2013 Global Market Shares of the Leading Suppliers of Peripheral DES Systems 
Exhibit 5-13: Estimated Geographic Distribution of Peripheral DES System Sales, Tabular, 2013 vs. 2018E 
Exhibit 5-14: Estimated Geographic Distribution of Peripheral DES System Sales, Graphic, 2013 vs. 2018E 
Exhibit 5-15: Selected Cerebral Thrombectomy Systems on the U.S. and International Markets 
Exhibit 5-16: Projected Dynamics of the Cerebral Thrombectomy Product Market, 2013-2018E 
Exhibit 5-17: Estimated 2013 Worldwide Market Shares of the Leading Suppliers of Cerebral Thrombectomy Systems 
Exhibit 5-18: Estimated Geographic Distribution of Cerebral Thrombectomy System Sales, Tabular, 2013 vs. 2018E 
Exhibit 5-19: Estimated Geographic Distribution of Cerebral Thrombectomy System Sales, Graphic, 2013 vs. 2018E 


APPENDIX A: COMPANY LISTING


COMPANIES COVERED:

  1. Aachen Resonance GmbH
  2. Abbott Laboratories
  3. Abbott Vascular, Inc.
  4. Acandis GmbH & Co. KG
  5. Alvimedica
  6. Balt Extrusion S.A.
  7. Bard Peripheral Vascular/C.R. Bard, Inc.
  8. Bayer AG
  9. Biotronik SE & Co. KG
  10. Biosensors International Ltd.
  11. Boston Scientific Corporation
  12. Cardionovum GmbH
  13. Codman/DePuy (Johnson & Johnson)
  14. Cook Medical, Inc./Cook Group, Inc.
  15. Cordis Corporation/Johnson & Johnson
  16. Covidien PLC/Medtronic, Inc.
  17. C.R. Bard, Inc.
  18. Eurocor GmbH
  19. iVascular S.L.U.
  20. Medrad/Bayer AG
  21. Medtronic, Inc.
  22. Neuravi, Ltd.
  23. Opto Circuits (India) Ltd.
  24. Penumbra, Inc.
  25. Phenox GmbH
  26. Stryker Corporation
  27. TriReme Medical Inc./QT Vascular Ltd.
Contact Us

Need help finding medtech research? Let us help you!